Aptargroup (ATR) Depreciation & Amortization (CF) (2009 - 2026)
Aptargroup (ATR) reported Depreciation & Amortization (CF) of $64.3 million for Q1 2026, up 17.13% year-over-year from $54.9 million in Q1 2025, and down 0.91% quarter-over-quarter from $64.9 million in Q4 2025.
Aptargroup (ATR) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $64.3 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $64.3 million, up 17.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $251.7 million (up 13.62% YoY), and the FY2025 annual result was $242.3 million, up 10.31% from the prior year.
- Depreciation & Amortization (CF) slipped to $64.3 million in Q1 2026 per ATR's latest filing, from $64.9 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $64.9 million in Q4 2025 and troughed at $46.9 million in Q3 2022.
- A 5-year average of $54.1 million and a median of $53.2 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) dropped 4.3% in 2022, then increased 17.13% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $48.1 million in 2022, then grew by 10.54% to $53.2 million in 2023, then rose by 6.75% to $56.7 million in 2024, then gained by 14.38% to $64.9 million in 2025, then declined by 0.91% to $64.3 million in 2026.
- Business Quant data shows ATR's Depreciation & Amortization (CF) at $64.3 million in Q1 2026, $64.9 million in Q4 2025, and $63.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 64.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.31 Mn |
| Mar 31, 2026 | 64.31 Mn |
| Dec 31, 2025 | 64.90 Mn |
| Dec 31, 2025 | 64.90 Mn |
| Sep 30, 2025 | 63.69 Mn |
| Sep 30, 2025 | 63.69 Mn |
| Jun 30, 2025 | 58.82 Mn |
| Jun 30, 2025 | 58.82 Mn |
| Mar 31, 2025 | 54.90 Mn |
| Mar 31, 2025 | 54.90 Mn |
| Dec 31, 2024 | 56.74 Mn |
| Dec 31, 2024 | 56.74 Mn |
| Sep 30, 2024 | 55.28 Mn |
| Sep 30, 2024 | 55.28 Mn |
| Jun 30, 2024 | 54.62 Mn |
| Jun 30, 2024 | 54.62 Mn |
| Mar 31, 2024 | 53.03 Mn |
| Mar 31, 2024 | 53.03 Mn |
| Dec 31, 2023 | 53.16 Mn |
| Dec 31, 2023 | 53.16 Mn |